A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE OF ANEMIA AMONG WOMEN OF REPRODUCTIVE AGE (15-50 YRS)

Background: Anemia remains a major public health problem worldwide, particularly among women of reproductive age. It contributes significantly to maternal morbidity, reduced work productivity, and adverse pregnancy outcomes. Despite ongoing national health programs, the burden of anemia continues to be high in developing countries. The study was conducted to access the prevalence of anemia among women of reproductive age who are living in rural areas around Narasaraopet. Objectives: To determine the prevalence of anemia among women of reproductive age and to assess its severity according to WHO guidelines for anemia classification. Methods: A prospective observational cross-sectional study was conducted among women aged 15–50 years attending GOVT HOSPITAL, NARASARAOPET from NOVEMBER 2025 to JANUARY 2026. The study included 100 women of reproductive age 15-50 years who are visiting the hospital for their routine checkups. Data was collected from the reports of the patients from the Dept of Obstetrics & Gynecology from Narasaraopeta Govt Hospital. Anemia was classified according to WHO criteria. Data were entered in Microsoft Excel and analyzed. Results: Among 100 women of reproductive age (15–50 years), the overall prevalence of anemia was 86%. Moderate anemia (43%) was the most common category, followed by mild anemia (34%), severe anemia (8%), and life-threatening anemia (1%), while 14% had normal hemoglobin levels. Anemia was more prevalent among pregnant women (95%) compared to non-pregnant women (83.75%). Age-wise analysis showed the highest burden among women aged 20–25 years, with consistently high prevalence across most reproductive age groups. Among pregnant women, anemia was observed across nearly all gestational age intervals (12–36 weeks), with an overall prevalence of 95% Conclusion: The study demonstrates a high prevalence of anemia among women of reproductive age. Early screening, nutritional education, and targeted public health interventions are essential to reduce the burden and associated complications.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-03-05
DOI
https://doi.org/10.5281/zenodo.18875479
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE OF ANEMIA AMONG WOMEN OF REPRODUCTIVE AGE (15-50 YRS)

1*Grandhe Purna Venkata Rajesh, 2Madisetty Naga Swapna Sri, 3Marri Mery, 4Nagaveni A., 5Thaticharla Pranathi, 6Dr. P. S. K. Suhil Azmi Pharm D., 7Dr. J. N. Suresh Kumar M. Pharm Ph. D.
Zenodo (CERN European Organization for Nuclear Research)
Iron Metabolism and Disorders
article

A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE OF ANEMIA AMONG WOMEN OF REPRODUCTIVE AGE (15-50 YRS)

1*Grandhe Purna Venkata Rajesh, 2Madisetty Naga Swapna Sri, 3Marri Mery, 4Nagaveni A., 5Thaticharla Pranathi, 6Dr. P. S. K. Suhil Azmi Pharm D., 7Dr. J. N. Suresh Kumar M. Pharm Ph. D.
article en

Abstract

Background: Anemia remains a major public health problem worldwide, particularly among women of reproductive age. It contributes significantly to maternal morbidity, reduced work productivity, and adverse pregnancy outcomes. Despite ongoing national health programs, the burden of anemia continues to be high in developing countries. The study was conducted to access the prevalence of anemia among women of reproductive age who are living in rural areas around Narasaraopet. Objectives: To determine the prevalence of anemia among women of reproductive age and to assess its severity according to WHO guidelines for anemia classification. Methods: A prospective observational cross-sectional study was conducted among women aged 15–50 years attending GOVT HOSPITAL, NARASARAOPET from NOVEMBER 2025 to JANUARY 2026. The study included 100 women of reproductive age 15-50 years who are visiting the hospital for their routine checkups. Data was collected from the reports of the patients from the Dept of Obstetrics & Gynecology from Narasaraopeta Govt Hospital. Anemia was classified according to WHO criteria. Data were entered in Microsoft Excel and analyzed. Results: Among 100 women of reproductive age (15–50 years), the overall prevalence of anemia was 86%. Moderate anemia (43%) was the most common category, followed by mild anemia (34%), severe anemia (8%), and life-threatening anemia (1%), while 14% had normal hemoglobin levels. Anemia was more prevalent among pregnant women (95%) compared to non-pregnant women (83.75%). Age-wise analysis showed the highest burden among women aged 20–25 years, with consistently high prevalence across most reproductive age groups. Among pregnant women, anemia was observed across nearly all gestational age intervals (12–36 weeks), with an overall prevalence of 95% Conclusion: The study demonstrates a high prevalence of anemia among women of reproductive age. Early screening, nutritional education, and targeted public health interventions are essential to reduce the burden and associated complications.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 32%
Iron Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE OF ANEMIA AMONG WOMEN OF REPRODUCTIVE AGE (15-50 YRS) — 1*Grandhe Purna Venkata Rajesh, 2Madisetty Naga Swapna Sri, 3Marri Mery, 4Nagaveni A., 5Thaticharla Pranathi, 6Dr. P. S. K. Suhil Azmi Pharm D., 7Dr. J. N. Suresh Kumar M. Pharm Ph. D. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS